HK1054382A1 - Substituted pyrroles. - Google Patents

Substituted pyrroles.

Info

Publication number
HK1054382A1
HK1054382A1 HK03106619A HK03106619A HK1054382A1 HK 1054382 A1 HK1054382 A1 HK 1054382A1 HK 03106619 A HK03106619 A HK 03106619A HK 03106619 A HK03106619 A HK 03106619A HK 1054382 A1 HK1054382 A1 HK 1054382A1
Authority
HK
Hong Kong
Prior art keywords
substituted pyrroles
pyrroles
substituted
Prior art date
Application number
HK03106619A
Other languages
English (en)
Inventor
Nader Fotouhi
Norman Kong
Allen John Lovey
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of HK1054382A1 publication Critical patent/HK1054382A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
HK03106619A 1999-12-22 2003-09-15 Substituted pyrroles. HK1054382A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17155799P 1999-12-22 1999-12-22
PCT/EP2000/013026 WO2001046178A2 (en) 1999-12-22 2000-12-21 Substituierte bisindolymaleimide

Publications (1)

Publication Number Publication Date
HK1054382A1 true HK1054382A1 (en) 2003-11-28

Family

ID=22624198

Family Applications (1)

Application Number Title Priority Date Filing Date
HK03106619A HK1054382A1 (en) 1999-12-22 2003-09-15 Substituted pyrroles.

Country Status (28)

Country Link
US (1) US6281356B1 (ru)
EP (1) EP1242409A2 (ru)
JP (1) JP2003518112A (ru)
KR (1) KR100508741B1 (ru)
CN (1) CN1193027C (ru)
AR (1) AR027035A1 (ru)
AU (1) AU782920B2 (ru)
BR (1) BR0016516A (ru)
CA (1) CA2394852A1 (ru)
CO (1) CO5090902A1 (ru)
CZ (1) CZ20022492A3 (ru)
HK (1) HK1054382A1 (ru)
HR (1) HRP20020536A2 (ru)
HU (1) HUP0204572A3 (ru)
IL (1) IL150200A0 (ru)
JO (1) JO2199B1 (ru)
MA (1) MA26860A1 (ru)
MX (1) MXPA02006162A (ru)
MY (1) MY133682A (ru)
NO (1) NO20022927L (ru)
NZ (1) NZ519359A (ru)
PE (1) PE20011098A1 (ru)
PL (1) PL357603A1 (ru)
RU (1) RU2261862C2 (ru)
UY (1) UY26498A1 (ru)
WO (1) WO2001046178A2 (ru)
YU (1) YU46302A (ru)
ZA (1) ZA200204313B (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030139373A1 (en) * 2001-11-20 2003-07-24 Breimer Lars Holger Method for cancer therapy
TWI324064B (en) 2002-04-03 2010-05-01 Novartis Ag Indolylmaleimide derivatives
GB0303319D0 (en) 2003-02-13 2003-03-19 Novartis Ag Organic compounds
MX2015012456A (es) 2013-03-15 2016-02-03 Plexxikon Inc Compuestos heterociclicos y usos de los mismos.
US20140303121A1 (en) 2013-03-15 2014-10-09 Plexxikon Inc. Heterocyclic compounds and uses thereof
PT3272745T (pt) 2016-07-21 2019-09-27 Inst Farmakologii Polskiej Akademii Nauk Derivados de indol substituídos com imidazolilo que se ligam ao recetor de serotonina 5-ht7 e composições farmacêuticas dos mesmos
EP3694855A1 (en) 2017-10-13 2020-08-19 Plexxikon Inc. Solid forms of a compound for modulating kinases

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK278989B6 (sk) 1988-02-10 1998-05-06 F. Hoffmann-La Roche Ag Substituované pyroly, ich použitie na výrobu lieči
US5380746A (en) 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
IL94274A0 (en) * 1989-05-05 1991-03-10 Goedecke Ag Maleinimide derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
AU3761393A (en) 1992-03-20 1993-10-21 Wellcome Foundation Limited, The Indole derivatives with antiviral activity
WO1993018766A1 (en) * 1992-03-20 1993-09-30 The Wellcome Foundation Limited Further indole derivatives with antiviral activity
DE4217964A1 (de) * 1992-05-30 1993-12-02 Goedecke Ag Indolocarbazol-Imide und deren Verwendung
PE91698A1 (es) 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos
PE91498A1 (es) 1996-07-29 1998-12-22 Hoffmann La Roche Pirroles sustituidos
PE91598A1 (es) 1996-07-29 1998-12-24 Hoffmann La Roche Pirroles sustituidos
EP1064279B1 (en) * 1998-03-17 2003-06-25 F.Hoffmann-La Roche Ag Substituted bisindolylmaleimides for the inhibition of cell proliferation

Also Published As

Publication number Publication date
NO20022927D0 (no) 2002-06-18
CA2394852A1 (en) 2001-06-28
MXPA02006162A (es) 2002-12-05
NO20022927L (no) 2002-06-18
RU2002119557A (ru) 2004-01-10
UY26498A1 (es) 2001-06-29
EP1242409A2 (en) 2002-09-25
JO2199B1 (en) 2003-12-23
AU782920B2 (en) 2005-09-08
ZA200204313B (en) 2003-08-29
US6281356B1 (en) 2001-08-28
CN1411457A (zh) 2003-04-16
CN1193027C (zh) 2005-03-16
KR20020062365A (ko) 2002-07-25
KR100508741B1 (ko) 2005-08-17
NZ519359A (en) 2004-04-30
PE20011098A1 (es) 2001-10-26
MY133682A (en) 2007-11-30
CO5090902A1 (es) 2001-10-30
JP2003518112A (ja) 2003-06-03
PL357603A1 (en) 2004-07-26
YU46302A (sh) 2005-06-10
HUP0204572A2 (en) 2003-05-28
CZ20022492A3 (cs) 2003-02-12
IL150200A0 (en) 2002-12-01
AR027035A1 (es) 2003-03-12
BR0016516A (pt) 2002-09-17
WO2001046178A2 (en) 2001-06-28
HRP20020536A2 (en) 2004-08-31
MA26860A1 (fr) 2004-12-20
RU2261862C2 (ru) 2005-10-10
HUP0204572A3 (en) 2004-07-28
WO2001046178A3 (en) 2001-12-06
AU3726701A (en) 2001-07-03

Similar Documents

Publication Publication Date Title
MXPA01013362A (es) Anticuerpos de humano, anti-alfavbeta3 recombinantes, °cidos nucleicos que codifican a los mismos y metodos de uso.
ZA200200477B (en) 2-pyrazolin-5-ones.
EG24361A (en) 4-pyrimiding1-n-acy1.l.phenlalanines
ZA200000894B (en) 4-Phenyl-pyridine derivatives.
ZA200201055B (en) Amino-triazolopyridine derivatives.
MXPA03004114A (es) Derivados de cianopirrolidina.
HK1051037A1 (en) Benzodiazepine derivatives.
ZA200202544B (en) Benzodiazepine derivatives.
ZA200202537B (en) Pour-on-formulations.
ZA200109595B (en) 13-methyl-erythromycin derivatives.
ZA200203284B (en) Decoy.
ZA200203762B (en) 4-pyridinyl-IN-acyl-L-phenylalanines.
HK1051199A1 (en) New phenylpiperazines.
HK1046411A1 (en) 5-Phenyl-pyrimidine derivatives.
HK1029502A1 (en) Slider-pull-assembling unit.
ZA200108968B (en) New compounds.
ZA992072B (en) Substituted pyrroles.
ZA200201276B (en) 3-Amino-2-phenyl-propane derivatives.
HK1054382A1 (en) Substituted pyrroles.
MXPA02000261A (es) Aminoindanos novedosos.
ZA200108481B (en) 8A- and 9A-15-membered lactams.
ZA200108913B (en) Imidazodiazepine derivative.
GB0029720D0 (en) I.S machine7544232001
MXPA01011285A (es) Derivados de tio-oxindol.
GC0000265A (en) Substituted pyrroles

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20081221